IRIS
MESSINA, Sonia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.824
NA - Nord America 11.639
AS - Asia 7.069
SA - Sud America 3.072
Continente sconosciuto - Info sul continente non disponibili 625
AF - Africa 225
OC - Oceania 19
AN - Antartide 1
Totale 35.474
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.319
RU - Federazione Russa 6.603
SG - Singapore 2.915
BR - Brasile 2.638
CN - Cina 2.006
IE - Irlanda 1.674
SE - Svezia 998
IT - Italia 831
HK - Hong Kong 732
DE - Germania 531
VN - Vietnam 494
PL - Polonia 478
FR - Francia 457
FI - Finlandia 365
UA - Ucraina 354
GB - Regno Unito 259
IN - India 209
AR - Argentina 158
CA - Canada 116
BD - Bangladesh 111
MX - Messico 101
IQ - Iraq 80
TR - Turchia 78
EC - Ecuador 76
ID - Indonesia 65
ZA - Sudafrica 64
NL - Olanda 53
AT - Austria 51
VE - Venezuela 47
CO - Colombia 45
MA - Marocco 45
UZ - Uzbekistan 45
BE - Belgio 41
PK - Pakistan 40
JP - Giappone 38
PY - Paraguay 32
ES - Italia 31
CL - Cile 27
KE - Kenya 26
CR - Costa Rica 25
CI - Costa d'Avorio 24
PE - Perù 22
TN - Tunisia 22
PH - Filippine 20
JO - Giordania 19
IL - Israele 18
NP - Nepal 18
SA - Arabia Saudita 18
AE - Emirati Arabi Uniti 17
JM - Giamaica 17
MY - Malesia 17
UY - Uruguay 17
AZ - Azerbaigian 16
CZ - Repubblica Ceca 16
KZ - Kazakistan 16
EG - Egitto 15
LT - Lituania 13
IR - Iran 12
OM - Oman 12
PA - Panama 12
DO - Repubblica Dominicana 11
EU - Europa 11
NI - Nicaragua 11
PT - Portogallo 11
NZ - Nuova Zelanda 10
PS - Palestinian Territory 10
AU - Australia 9
DZ - Algeria 9
HN - Honduras 9
LB - Libano 9
AL - Albania 8
BO - Bolivia 8
KW - Kuwait 7
RO - Romania 7
RS - Serbia 7
AO - Angola 6
GT - Guatemala 5
HU - Ungheria 5
KR - Corea 5
LK - Sri Lanka 5
QA - Qatar 5
CY - Cipro 4
HR - Croazia 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
TH - Thailandia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
GE - Georgia 3
NG - Nigeria 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AM - Armenia 2
CH - Svizzera 2
GA - Gabon 2
GR - Grecia 2
Totale 34.826
Salva come PNG Salva come JPEG
Città #
Moscow 2.091
Dublin 1.668
Ashburn 1.563
Singapore 1.499
Dallas 1.133
Chandler 1.055
Jacksonville 798
Beijing 734
Hong Kong 732
Nyköping 568
Council Bluffs 505
San Jose 472
Warsaw 461
The Dalles 403
Princeton 363
Medford 307
Lauterbourg 283
Cambridge 261
Los Angeles 246
Des Moines 219
Ann Arbor 210
Messina 189
Dearborn 182
São Paulo 175
Ho Chi Minh City 159
Buffalo 148
Boardman 147
Munich 126
New York 109
San Mateo 94
Hanoi 92
Lancaster 92
Tianjin 89
Redondo Beach 88
Rio de Janeiro 78
Shenyang 75
Wilmington 73
Rome 72
Jinan 71
Pune 70
Bremen 67
Santa Clara 67
Turku 64
Guangzhou 62
Belo Horizonte 57
Frankfurt am Main 56
Nanjing 54
Brasília 52
Houston 52
Orem 48
Porto Alegre 47
Curitiba 46
Woodbridge 45
Tashkent 43
Atlanta 40
Baghdad 39
Brussels 38
Dong Ket 38
Nuremberg 37
Hangzhou 36
Brooklyn 35
Chennai 35
Tokyo 35
Campinas 34
Zhengzhou 33
Guarulhos 32
Hebei 32
Ningbo 32
Shanghai 32
Milan 28
Phoenix 28
Vienna 28
Johannesburg 27
Montreal 27
Seattle 27
Toronto 27
Ribeirão Preto 26
Guayaquil 25
Helsinki 25
Jakarta 25
Quito 25
Abidjan 24
Amsterdam 23
Haikou 23
Taizhou 22
Lappeenranta 21
Mexico City 21
San Francisco 21
Stockholm 21
Changsha 20
Chicago 20
London 20
Nairobi 20
Nanchang 20
Salvador 20
Sorocaba 20
São José do Rio Preto 20
Asunción 19
Dhaka 19
Fortaleza 19
Totale 19.699
Salva come PNG Salva come JPEG
Nome #
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 256
24-Holter ECG in type II and III SMA 251
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 245
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 241
A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript “single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1” written by pechmann and colleagues” 228
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. 211
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 201
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 201
A new form of alpha-dystroglycanopathy associated with severe drug-resistant epilepsy and unusual EEG features 197
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 197
Alexithymia, burden and resilience in ALS’ caregivers 197
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 194
Hippo signaling pathway is altered in Duchenne muscular dystrophy 192
Effect of exercise on telomere length and telomere proteins expression in mdx mice 192
Nusinersen versus sham control in later-onset spinal muscular atrophy 192
Autonomic nervous system involvement in spinal muscular atrophy. 191
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 191
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 184
An observational study of functional abilities in infants, children, and adults with type 1 SMA 184
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 182
ANT1 is reduced in sporadic inclusion body myositis. 180
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 179
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 178
Pilot study of flavocoxid in ambulant DMD patients. 174
Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis 174
6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes 173
Pilot study of serial casting in muscular dystrophy patients. 171
Apoptosis and apoptosis-related proteins in thyroid myopathies 170
Pilot study of serial casting of ankles in muscular dystrophy patients. 168
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 168
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 167
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen 167
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 164
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 162
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 162
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 161
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 160
Functional changes in Duchenne muscular dystrophy: A 12-month longitudinal cohort study. 159
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 159
Age and baseline values predict 12 and 24-month functional changes in type 2 SMA 159
Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci 158
Impaired myocardial deformation revealing subclinical left ventricular dysfunction in children with Duchenne dystrophy: a speckle tracking echocardiography study 158
Emotional burden and coping strategies in amyotrophic lateral sclerosis caregivers: The role of metacognitions 158
Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance 158
A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy 158
A comprehensive molecular approach in COLA6 related myopathies based on genomic sequencing, transcriptional analysis and array CGH. 157
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 157
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life InventoryTM Neuromuscular Module in the Italian population and correlation with other functional assessments. 157
The 24-month PUL changes and steroids correlation. 155
Genomic Variations Affecting Biological Effects of Statins 154
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 154
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 153
Pilot study of flavocoxid in ambulant DMD patients. 152
Severe rhabdomyolysis in a patient with “Heat Stroke” 152
Pilot study of flavocoxid in ambulant DMD patients. 152
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 150
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 150
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis 150
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 150
Burden, social network and professional support in the families of patients with muscular dystrophies: results from the GUP10002 study. 148
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy 148
Clinical variability in spinal muscular atrophy type III 148
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 146
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 146
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes 145
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 145
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 145
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy 144
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 144
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 144
Cardiac function in types II and III spinal muscular atrophy: should we change standards of care? 144
Development of an academic disease registry for spinal muscular atrophy 144
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 144
Conceptualizing the relations between metacognition and executive functions in Amyotrophic Lateral Sclerosis (ALS) patients’ caregivers. A preliminary study 140
Clinical and genetic spectrum in a large cohort of patients with a genetic diagnosis of Congenital Muscular Dystrophies in the UK and differences with the Italian population 140
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 139
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data 139
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 138
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data 138
Timed rise from floor as a predictor of disease progression in Duchenne muscular dystrophy: An observational study 137
Teriparatide (rhPTH) treatment in Duchenne Muscular Dystrophy, a case report. 137
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 136
Expression of the trascription factor NFkB in different muscular dystrophies 135
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle 134
A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review 132
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with neuromuscolar disorders: a speckle tracking study 132
6 min walking test 12 month changes in DMD: Correlation with genotype. 132
Implication of SIRT1 and its downstream pathways in dystrophic process. 132
study of flavocoxid in ambulant DMD patients. 131
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 130
The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability. 130
Histological effects of givinostat in boys with Duchenne muscular dystrophy 130
Muscle Fat-Fraction and Mapping in Duchenne Muscular Dystrophy: Evaluation of Disease Distribution and Correlation with Clinical Assessments: A preliminary experience. 129
Bone quality in Duchenne muscular dystrophy 128
Clinical and genetic spectrum in a large cohort of patients with a genetic diagnosis of Congenital Muscular Dystrophies: Analysis of the UK diagnostic service 2001-2013. 127
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 123
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 123
Pilot study of flavocoxid in ambulant DMD patients. 123
Dual-echo dual flip angle gradient-echo MRI technique for quantification of muscle fat fraction in Duchenne muscular dystrophy: a new valuable outcome measure. 122
The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys 122
Totale 16.009
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.199
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.199
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.679 0 123 13 113 97 14 125 71 51 116 211 745
2022/20234.386 391 318 161 309 379 382 29 236 1.999 21 122 39
2023/20241.108 84 200 73 100 112 214 46 31 16 43 28 161
2024/20255.731 98 76 102 350 246 151 161 1.365 1.509 327 431 915
2025/202616.199 694 1.196 1.308 1.300 1.184 3.515 1.894 1.877 1.907 708 335 281
2026/20271.198 353 845 0 0 0 0 0 0 0 0 0 0
Totale 35.474